Literature DB >> 6323445

cAMP-dependent protein kinase stimulates epidermal growth factor-dependent phosphorylation of epidermal growth factor receptors.

P Ghosh-Dastidar, C F Fox.   

Abstract

Epidermal growth factor (EGF)-dependent transfer of radiolabeled phosphate from [gamma-32P]ATP to 160-kDa EGF receptor solubilized from human epidermoid carcinoma A431 cell surface membranes was stimulated up to 3-fold by addition of 3',5'-cAMP and purified cAMP-dependent protein kinase. Phosphorylation of EGF receptors was stimulated to the same extent when cAMP-dependent protein kinase catalytic subunit was substituted for 3',5'-cAMP and cAMP-dependent protein kinase. Phosphoamino acid analysis revealed that the extent of phosphorylation of EGF receptor at tyrosine residues was the same regardless of whether cAMP-dependent protein kinase catalytic subunit was present in or omitted from the system. Increased EGF receptor phosphorylation occurring in response to cAMP-dependent protein kinase catalytic subunit was accounted for by phosphorylation at serine or threonine residues. In samples phosphorylated in the presence of cAMP-dependent protein kinase catalytic subunit, phosphate was present in tyrosine, serine, and threonine in a ratio of 32:60:8. Two-dimensional mapping of radiolabeled phosphopeptides produced from EGF receptors by digestion with trypsin revealed the generation of one additional major phosphoserine-containing peptide when cAMP-dependent protein kinase was present with EGF in the EGF receptor kinase system. Degradation of 160-kDa EGF receptors to a 145-kDa form by purified Ca2+-activated neutral protease produced a 145-kDa fragment with phosphoserine content increased over that present initially in the 160-kDa precursor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323445

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Effect of cyclic AMP-dependent protein kinase on insulin receptor tyrosine kinase activity.

Authors:  J F Tanti; T Grémeaux; N Rochet; E Van Obberghen; Y Le Marchand-Brustel
Journal:  Biochem J       Date:  1987-07-01       Impact factor: 3.857

2.  Tyrosine phosphorylation in Myxococcus xanthus, a multicellular prokaryote.

Authors:  S C Frasch; M Dworkin
Journal:  J Bacteriol       Date:  1996-07       Impact factor: 3.490

3.  Epidermal growth factor receptor expression, proliferation, and colony stimulating activity production in the urinary bladder carcinoma cell line 5637.

Authors:  M Häder; D Stach-Machado; K H Pflüger; M Rotsch; B Heimann; K Moelling; K Havemann
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

4.  Second messenger modulation of epidermal growth factor receptor function does not occur at the level of receptor dimerization.

Authors:  G F Verheijden; I Verlaan; M J van Iersel; W H Moolenaar
Journal:  Biochem J       Date:  1990-10-01       Impact factor: 3.857

5.  K-BILDS: A Kinase Substrate Discovery Tool.

Authors:  D Maheeka Embogama; Mary Kay H Pflum
Journal:  Chembiochem       Date:  2016-12-07       Impact factor: 3.164

6.  Heterodimerization of the epidermal-growth-factor (EGF) receptor and ErbB2 and the affinity of EGF binding are regulated by different mechanisms.

Authors:  L E Johannessen; K E Haugen; A C østvold; E Stang; I H Madshus
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

7.  Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells.

Authors:  L M Graves; K E Bornfeldt; E W Raines; B C Potts; S G Macdonald; R Ross; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

8.  PC12 cell mutants that possess low- but not high-affinity nerve growth factor receptors neither respond to nor internalize nerve growth factor.

Authors:  S H Green; R E Rydel; J L Connolly; L A Greene
Journal:  J Cell Biol       Date:  1986-03       Impact factor: 10.539

9.  Mutation of tyrosine-141 inhibits insulin-promoted tyrosine phosphorylation and increased responsiveness of the human beta 2-adrenergic receptor.

Authors:  M Valiquette; S Parent; T P Loisel; M Bouvier
Journal:  EMBO J       Date:  1995-11-15       Impact factor: 11.598

10.  Epidermal growth factor receptor levels are reduced in mice with targeted disruption of the protein kinase A catalytic subunit.

Authors:  Morten P Oksvold; Ane Funderud; Anne-Katrine Kvissel; Ellen Skarpen; Heidi Henanger; Henrik S Huitfeldt; Bjørn S Skålhegg; Sigurd Ørstavik
Journal:  BMC Cell Biol       Date:  2008-04-01       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.